[{"evidenceId":18963,"evidenceType":"GENE_SUMMARY","shortDesc":null,"desc":"NOTCH3 encodes a Type I transmembrane protein of the Notch family that functions as receptor for Jagged1/2, and Delta 1, and regulates cell-fate determination through the NOTCH signaling pathway. Missense and nonsense mutations in NOTCH3 in head and neck squamous cell carcinoma, breast, colorectal, melanoma, glioblastoma, liver, lung, ovarian, and prostate have been identified. NOTCH3 overexpression correlates with better overall survival in ovarian cancer.","id":null,"lastEdit":"2017-01-17","status":null,"gene":{"entrezGeneId":4854,"hugoSymbol":"NOTCH3","name":"notch 3","oncogene":false,"curatedIsoform":"ENST00000263388","curatedRefSeq":"NM_000435.2","geneAliases":["CADASIL","IMF2","LMNS","CASIL","CADASIL1"],"tsg":false},"articles":[]},{"evidenceId":18964,"evidenceType":"GENE_BACKGROUND","shortDesc":null,"desc":"NOTCH3 encodes a Type I transmembrane protein of the Notch family that functions as receptor for Jagged1/2, and Delta 1, and play a key role in cellular signaling and regulates cell-fate determination through the NOTCH signaling pathway (PMID: 19165418). NOTCH3 mutations were initially identified in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) (PMID: 26715087). Expression studies have also shown elevated NOTCH3 expression during cellular senescence and loss-of-function mutations that interrupt senescence are identified in several types of cancer including head and neck carcinoma, breast, colorectal, melanoma, glioblastoma,liver, lung, ovarian, and prostate cancer. (PMID: 23610446) In a recent study of NOTCH3 expression in ovarian cancer, overexpression of NOTCH3 associated with better overall survival (PMID: 26662955).","id":null,"lastEdit":"2017-01-17","status":null,"gene":{"entrezGeneId":4854,"hugoSymbol":"NOTCH3","name":"notch 3","oncogene":false,"curatedIsoform":"ENST00000263388","curatedRefSeq":"NM_000435.2","geneAliases":["CADASIL","IMF2","LMNS","CASIL","CADASIL1"],"tsg":false},"articles":[{"pmid":"23610446","title":"Notch3 functions as a tumor suppressor by controlling cellular senescence.","journal":"Cancer research","pubDate":"2013 Jun 1","volume":"73","issue":"11","pages":"3451-9","authors":"Cui H et al","elocationId":"doi: 10.1158/0008-5472.CAN-12-3902","link":null,"reference":"Cui H et al. Cancer research. 2013 Jun 1;73(11)3451-9.","abstract":null},{"pmid":"26662955","title":"Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer.","journal":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","pubDate":"2016 May","volume":"37","issue":"5","pages":"6979-85","authors":"Zhou X et al","elocationId":"doi: 10.1007/s13277-015-4594-5","link":null,"reference":"Zhou X et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016 May;37(5)6979-85.","abstract":null},{"pmid":"19165418","title":"The Notch signaling pathway: transcriptional regulation at Notch target genes.","journal":"Cellular and molecular life sciences : CMLS","pubDate":"2009 May","volume":"66","issue":"10","pages":"1631-46","authors":"Borggrefe T et al","elocationId":"doi: 10.1007/s00018-009-8668-7","link":null,"reference":"Borggrefe T et al. Cellular and molecular life sciences : CMLS. 2009 May;66(10)1631-46.","abstract":null},{"pmid":"26715087","title":"The NOTCH3 score: a pre-clinical CADASIL biomarker in a novel human genomic NOTCH3 transgenic mouse model with early progressive vascular NOTCH3 accumulation.","journal":"Acta neuropathologica communications","pubDate":"2015 Dec 29","volume":"3","issue":"","pages":"89","authors":"Rutten JW et al","elocationId":"doi: 10.1186/s40478-015-0268-1","link":null,"reference":"Rutten JW et al. Acta neuropathologica communications. 2015 Dec 29;3()89.","abstract":null}]}]